Analysis of microRNA-199a-3p expression in CD4+ T cells of systemic lupus erythematosus
- PMID: 36763225
- DOI: 10.1007/s10067-023-06534-7
Analysis of microRNA-199a-3p expression in CD4+ T cells of systemic lupus erythematosus
Abstract
Objectives: Accumulating evidence have suggested microRNAs (miRNAs) play important roles in the pathogenesis of systemic lupus erythematosus (SLE). Here we aimed to explore aberrant expression of miRNAs in CD4+ T cells from SLE patients and their potential function in SLE pathogenesis.
Methods: First, next-generation sequencing was performed on CD4+ T cells from four SLE patients and three healthy controls (HCs). Candidate miRNAs were then validated in CD4+ T cells from 97 patients with SLE, 16 patients with rheumatoid arthritis, and 12 HCs using qRT-PCR. Then the relationship between the candidate miRNA and clinical characteristics was analyzed. Bioinformatics analysis and validation of the target genes of the candidate miRNA were performed.
Results: A total of 66 upregulated miRNAs and 70 downregulated miRNAs were found between SLE and normal CD4+ T cells samples. miR-199a-3p was identified significant upregulation in the CD4+ T cells of lupus patients. High expression of miR-199a-3p was correlated with several clinical characteristics including low C3 level, positive anti-dsDNA antibody, high ESR level, active lupus nephritis, and active disease activity. When distinguishing active LN from non-LN or active lupus from stable lupus, the AUCs of miR-199a-3p were 0.68 and 0.70, respectively. And the expression of miR-199a-3p, involved in JAK-STAT signaling pathway, was negatively correlated with the STAM expression in CD4+ T cells of SLE.
Conclusion: Our study suggested a novel and promising role of miR-199a-3p in CD4+ T cells for SLE. Further studies are needed to precisely determine the function of miR-199a-3p in this disease. Key Points • Aberrant expression of miRNAs in CD4+ T cells and their potential function in SLE pathogenesis remained unclear. • miR-199a-3p in CD4+ T cells plays a novel role in the pathogenesis of SLE and serves as a potential target for SLE.
Keywords: Biomarker; CD4+ T cells; JAK-STAT signaling pathway; Systemic lupus erythematosus; microRNA.
© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Similar articles
-
miR-132-3p downregulates FOXO1 in CD4+ T cells and is associated with disease manifestations in patients with lupus.J Int Med Res. 2024 Oct;52(10):3000605241286762. doi: 10.1177/03000605241286762. J Int Med Res. 2024. PMID: 39429035 Free PMC article.
-
Circulatory microRNAs and proinflammatory cytokines as predictors of lupus nephritis.Front Immunol. 2024 Oct 11;15:1449296. doi: 10.3389/fimmu.2024.1449296. eCollection 2024. Front Immunol. 2024. PMID: 39464895 Free PMC article.
-
Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus.Inflamm Res. 2021 Mar;70(3):285-296. doi: 10.1007/s00011-020-01433-y. Epub 2021 Jan 28. Inflamm Res. 2021. PMID: 33507312
-
Comprehensive review of genetic association studies and meta-analysis on miRNA polymorphisms and rheumatoid arthritis and systemic lupus erythematosus susceptibility.Hum Immunol. 2016 Jan;77(1):1-6. doi: 10.1016/j.humimm.2014.09.002. Epub 2014 Sep 16. Hum Immunol. 2016. PMID: 25218914 Review.
-
Candidate MicroRNA Biomarkers in Lupus Nephritis: A Meta-analysis of Profiling Studies in Kidney, Blood and Urine Samples.Mol Diagn Ther. 2023 Mar;27(2):141-158. doi: 10.1007/s40291-022-00627-w. Epub 2022 Dec 15. Mol Diagn Ther. 2023. PMID: 36520403
Cited by
-
MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy.Clin Exp Med. 2023 Dec;23(8):4065-4077. doi: 10.1007/s10238-023-01234-7. Epub 2023 Nov 3. Clin Exp Med. 2023. PMID: 37921874 Review.
-
An updated review on abnormal epigenetic modifications in the pathogenesis of systemic lupus erythematosus.Front Immunol. 2025 Jan 6;15:1501783. doi: 10.3389/fimmu.2024.1501783. eCollection 2024. Front Immunol. 2025. PMID: 39835138 Free PMC article. Review.
-
MicroRNAs as Key Regulators in RA and SLE: Insights into Biological Functions.Curr Pharm Des. 2024;30(22):1746-1761. doi: 10.2174/0113816128303695240512141729. Curr Pharm Des. 2024. PMID: 38798216 Review.
References
-
- Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110–2121. https://doi.org/10.1056/NEJMra1100359 - DOI - PubMed
-
- Doria A, Gatto M, Zen M, Iaccarino L, Punzi L (2014) Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev 13(7):770–777. https://doi.org/10.1016/j.autrev.2014.01.055 - DOI - PubMed
-
- Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC (2017) Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med 23(7):615–635. https://doi.org/10.1016/j.molmed.2017.05.006 - DOI - PubMed - PMC
-
- Morel L (2017) Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol 13(5):280–290. https://doi.org/10.1038/nrrheum.2017.43 - DOI - PubMed
-
- Teng X, Brown J, Choi SC, Li W, Morel L (2020) Metabolic determinants of lupus pathogenesis. Immunol Rev 295(1):167–186. https://doi.org/10.1111/imr.12847 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous